Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021

  • ID: 4062499
  • Report
  • Region: Global
  • 140 Pages
  • Markets and Markets
1 of 6
The Global Regenerative Medicine Market is Expected to Reach USD 38.70 Billion By 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6% from 2016 to 2021

FEATURED COMPANIES

  • Cook Biotech Incorporated
  • Medtronic Plc
  • Nuvasive, Inc.
  • Organogenesis Inc.
  • Osiris Therapeutics, Inc.
  • Stryker Corporation
  • MORE

The major factor driving the growth of regenerative medicine market, are government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.

The global Regenerative medicine market is segmented based on type, therapy, application, and regions. The cell-based products segment is expected to register to have largest market share in the Regenerative medicine market, by type, during the forecast period. The high growth in this segment is attributed to the increasing awareness about stem cell therapy, growing funding for new stem cell lines, and development of advanced genomic methods.

On the basis of therapy, the cell therapy procedure is expected to account for the largest share of the market in 2016. Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies will drive the growth of this market.

On the basis of applications, the segments are orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is the fastest growing application market. Increasing cancer incidence, rich product pipeline and increasing demand for cancer treatments fuelling the growth of the market.

Geographically, the Regenerative medicine market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rapidly increasing aging population and increase in chronic diseases are the major drivers for developed economies like the U.S.

The key players in the cell-based products segment are Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.). The key players in the acellular products segment are Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).

Research Coverage:
The report analyses the Regenerative medicine market by type, therapy, application and regions. Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the Regenerative medicine market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the Regenerative medicine market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the Regenerative medicine market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the Regenerative medicine market
  • Market Development: Comprehensive information about emerging markets. This report analyses the market for various Regenerative medicine market products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Regenerative medicine market.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Cook Biotech Incorporated
  • Medtronic Plc
  • Nuvasive, Inc.
  • Organogenesis Inc.
  • Osiris Therapeutics, Inc.
  • Stryker Corporation
  • MORE
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown And Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data from Secondary Sources
2.3.2 Key Data from Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Regenerative Medicine: Market Overview
4.2 Geographic Analysis: Regenerative Medicine Market,  By Therapy, 2016
4.3 Geographical Snapshot of the Regenerative Medicine Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Government & Private Funding to Support the Development of Regenerative Medicine
5.3.2 Rising Prevalence of Chronic Diseases And Genetic Disorders
5.3.3 Increase in Global Healthcare Expenditure
5.3.4 Rapid Growth in the Aging Population
5.3.5 Increase in Corporate Partnerships to Accelerate Development And Commercialization of Regenerative Medicine
5.4 Restraints
5.4.1 Ethical Concerns With the Use of Embryonic Stem Cell for R&D
5.4.2 Lack of Clear Regulatory Guidelines
5.5 Opportunities
5.5.1 Rising Demand for Organ Transplantation
5.5.2 Strong Product Pipeline

6 Global Regenerative Medicine Market, By Product
6.1 Introduction
6.2 Cell-Based Products
6.2.1 Allogeneic Products
6.2.2 Autologous Products
6.3 Acellular Products

7 Global Regenerative Medicine Market, By Therapy
7.1 Introduction
7.2 Cell Therapy
7.3 Tissue Engineering
7.4 Immunotherapy
7.5 Gene Therapy

8 Regenerative Medicine Market, By Application
8.1 Introduction
8.2 Orthopedic & Musculoskeletal Disorders
8.3 Dermatology
8.4 Cardiology
8.5 Central Nervous System Diseases
8.6 Oncology
8.7 Diabetes
8.8 Other Applications

9 Global Regenerative Medicine Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada 72
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (Roe)
9.4 Asia-Pacific
9.5 Rest of the World (Row)

10 Competitive Landscape
10.1 Overview
10.2 Market Ranking
10.3 Competitive Situation And Trends
10.3.1 Acquisitions
10.3.2 Partnerships
10.3.3 Regulatory Approvals
10.3.4 New Product Developments
10.3.5 Others

11 Company Profiles
(Overview, Financial - , Products & Services, Strategy, And Developments)
11.1 Acelity L.P. Inc. (Kci Licensing)
11.2 Nuvasive, Inc.
11.3 Vericel Corporation
11.4 Osiris Therapeutics, Inc.
11.5 Integra Lifesciences Corporation
11.6 Stryker Corporation
11.7 Medtronic Plc
11.8 Cook Biotech Incorporated
11.9 Organogenesis Inc.
11.10 Japan Tissue Engineering Co., Ltd. (Subsidiary of Fujifilm Holdings Corporation)
  • Details Might Not Be Captured in Case of Unlisted Companies.
12 Appendix
12.1 Insights from Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing Rt: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details

List of Tables:
Table 1 Key Corporate Partnerships, 2016
Table 2 Gene Therapy Products in Clinical Trials, 2016
Table 3 Cell And Gene Therapy Clinical Product Pipeline, 2016
Table 4 Global Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Table 5 Cell-Based Products Market Size, By Region, 2014-2021 (USD Billion)
Table 6 Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 7 Allogeneic Products Market Size, By Region, 2014-2021 (USD Billion)
Table 8 Autologous Products Market Size, By Region, 2014-2021 (USD Billion)
Table 9 Acellular Products Market Size, By Region, 2014-2021 (USD Billion)
Table 10 Global Regenerative Medicine Market Size, By Therapy,  2014-2021 (USD Billion)
Table 11 Stem Cell Therapies in Phase Iii Development, 2016
Table 12 Cell Therapy Market Size, By Region, 2014-2021 (USD Billion)
Table 13 Tissue Engineering Market Size, By Region, 2014-2021 (USD Billion)
Table 14 Immunotherapy Market Size, By Region, 2014-2021 (USD Billion)
Table 15 Gene Therapies in Clinical Trials, 2016
Table 16 Gene Therapy Market Size, By Region, 2014-2021 (USD Billion)
Table 17 Number of Clinical Trials for Regenerative Medicine, By Therapeutic Category (2016)
Table 18 Number of Clinical Trials for Regenerative Medicine, By Phase (2016)
Table 19 Regenerative Medicine Market Size, By Application, 2014-2021 (USD Billion)
Table 20 Orthopedic & Musculoskeletal Disorders Market Size, By Region,  2014-2021 (USD Billion)
Table 21 Dermatology Market Size, By Region, 2014-2021 (USD Billion)
Table 22 Cardiology Market Size, By Region, 2014-2021 (USD Billion)
Table 23 Central Nervous System Diseases Market Size, By Region,  2014-2021 (USD Billion)
Table 24 Cancer Patients (Global), By Cancer Type, 2015-2035
Table 25 Oncology Market Size, By Region, 2014-2021 (USD Billion)
Table 26 Diabetes Market Size, By Region, 2014-2021 (USD Billion)
Table 27 Other Applications Market Size, By Region, 2014-2021 (USD Billion)
Table 28 Global Regenerative Medicine Market Size, By Region, 2014-2021 (USD Billion)
Table 29 North America: Regenerative Medicine Market Size, By Country,  2014-2021 (USD Billion)
Table 30 North America: Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Table 31 North America: Cell-Based Products Market Size, By Type,  2014-2021 (USD Billion)
Table 32 North America: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 33 North America: Regenerative Medicine Market Size, By Therapy,  2014-2021 (USD Billion)
Table 34 U.S.: Regenerative Medicine Market Size, By Product, 2014-2021 (USD Billion)
Table 35 U.S.: Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 36 U.S.: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 37 U.S.: Regenerative Medicine Market Size, By Therapy, 2014-2021 (USD Billion)
Table 38 Canada: Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Table 39 Canada: Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 40 Canada: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 41 Canada: Regenerative Medicine Market Size, By Therapy,  2014-2021 (USD Billion)
Table 42 Europe: Regenerative Medicine Market Size, By Country,  2014-2021 (USD Billion)
Table 43 Europe: Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Table 44 Europe: Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 45 Europe: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 46 Europe: Regenerative Medicine Market Size, By Therapy,  2014-2021 (USD Billion)
Table 47 Germany: Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Table 48 Germany: Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 49 Germany: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 50 Germany: Regenerative Medicine Market Size, By Therapy,  2014-2021 (USD Billion)
Table 51 U.K.: Regenerative Medicine Market Size, By Product, 2014-2021 (USD Billion)
Table 52 U.K.: Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 53 U.K.: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 54 U.K.: Regenerative Medicine Market Size, By Therapy, 2014-2021 (USD Billion)
Table 55 France: Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Table 56 France: Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 57 France: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 58 France: Regenerative Medicine Market Size, By Therapy,  2014-2021 (USD Billion)
Table 59 Italy: Regenerative Medicine Market Size, By Product, 2014-2021 (USD Billion)
Table 60 Italy: Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 61 Italy: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 62 Italy: Regenerative Medicine Market Size, By Therapy, 2014-2021 (USD Billion)
Table 63 Spain: Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Table 64 Spain: Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 65 Spain: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 66 Spain: Regenerative Medicine Market Size, By Therapy, 2014-2021 (USD Billion)
Table 67 Roe: Regenerative Medicine Market Size, By Product, 2014-2021 (USD Billion)
Table 68 Roe: Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 69 Roe: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 70 Roe: Regenerative Medicine Market Size, By Therapy, 2014-2021 (USD Billion)
Table 71 Asia-Pacific: Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Table 72 Asia: Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 73 Asia-Pacific: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 74 Asia-Pacific: Regenerative Medicine Market Size, By Therapy,  2013-2021 (USD Billion)
Table 75 Row: Regenerative Medicine Market Size, By Product, 2014-2021 (USD Billion)
Table 76 Row: Cell-Based Products Market Size, By Type, 2014-2021 (USD Billion)
Table 77 Row: Regenerative Medicine Market Size, By Application,  2014-2021 (USD Billion)
Table 78 Row: Regenerative Medicine Market Size, By Therapy, 2014-2021 (USD Billion)
Table 79 Ranking of Major Players in the Global Cell-Based Regenerative Medicine Market (2015)
Table 80 Ranking of Major Players in the Global Acellular Regenerative Medicine Market (2015)
Table 81 Key Products in the Cell-Based Regenerative Medicine Market (2015)
Table 82 Key Products in the Acellular Regenerative Medicine Market (2015)
Table 83 Acquisitions, 2014-2017
Table 84 Partnerships, 2014-2016
Table 85 Regulatory Approvals, 2014-2016
Table 86 New Product Developments, 2013-2016
Table 87 Others, 2014-2016

List of Figures:
Figure 1 Research Design
Figure 2 Market Size Estimation Methodology: Bottom-Up Approach
Figure 3 Market Size Estimation Methodology: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, And Region
Figure 5 Data Triangulation Methodology
Figure 6 Cell-Based Products to Lead the Market During the Forecast Period
Figure 7 Cell Therapy to Dominate the Regenerative Medicine Market By 2021
Figure 8 Global Regenerative Medicine Market, By Application, 2016 Vs. 2021
Figure 9 North America to Lead the Regenerative Medicine Market During  the Forecast Period
Figure 10 Global Regenerative Medicine Market to Register High, Double-Digit Growth from 2016 to 2021
Figure 11 Cell Therapy Segment to Dominate the Regenerative Medicine Market in 2016
Figure 12 Asia-Pacific to Be the Fastest-Growing Region in the Forecast Period
Figure 13 Global Regenerative Medicine Market: Drivers, Restraints, Opportunities, And Challenges
Figure 14 Global Regenerative Medicine Market Segmentation, By Product
Figure 15 Cell-Based Products to Command the Largest Share of the Global Regenerative Medicine Market in 2016
Figure 16 Cell-Based Products Market Segmentation, By Type
Figure 17 Cell Therapy to Dominate the Regenerative Medicine Market During the Forecast Period
Figure 18 Orthopedic & Musculoskeletal Disorders Segment to Dominate the Regenerative Medicine Applications Market in 2016
Figure 19 Number of Diabetes Cases, 2015 Vs. 2040 (Million)
Figure 20 North America: Regenerative Medicine Market Snapshot
Figure 21 North America: Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Figure 22 U.S.: Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Figure 23 Europe: Regenerative Medicine Market Snapshot
Figure 24 Europe: Regenerative Medicine Market Size, By Therapy,  2014-2021 (USD Billion)
Figure 25 Germany: Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Figure 26 Asia-Pacific: Regenerative Medicine Market Snapshot
Figure 27 Asia-Pacific.: Regenerative Medicine Market Size, By Product,  2014-2021 (USD Billion)
Figure 28 Rest of the World: Regenerative Medicine Market Snapshot
Figure 29 Row: Regenerative Medicine Market Size, By Therapy,  2014-2021 (USD Billion)
Figure 30 Leading Market Players Adopted Both Organic And Inorganic Growth Strategies Over the Last Four Years (2013-2017)
Figure 31 Battle for Market Share: New Product Launches & Product Enhancements Are the Key Strategies
Figure 32 Acelity (Kci Licensing): Company Snapshot (2015)
Figure 33 Nuvasive, Inc.: Company Snapshot (2015)
Figure 34 Vericel Corporation: Company Snapshot (2015)
Figure 35 Osiris Therapeutics, Inc.: Company Snapshot (2014)
Figure 36 Integra Lifesciences Corporation: Company Snapshot (2015)
Figure 37 Medtronic Plc: Company Snapshot (2016)
Figure 38 Japan Tissue Engineering Co., Ltd: Company Snapshot (2015)
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Acelity L.P. Inc. (Kci Licensing)
  • Cook Biotech Incorporated
  • Integra Lifesciences Corporation
  • Japan Tissue Engineering Co., Ltd. (Subsidiary of Fujifilm Holdings Corporation)
  • Medtronic Plc
  • Nuvasive, Inc.
  • Organogenesis Inc.
  • Osiris Therapeutics, Inc.
  • Stryker Corporation
  • Vericel Corporation
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll